Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Patent: 8,748,475

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,748,475
Title:Methods and compositions for treating lupus
Abstract: The invention relates to compositions and methods for treating lupus. The methods typically comprise the step of administrating one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA in an amount sufficient to treat the lupus; preferably by modulating cytokine expression. Preferably the compound is in an amount less than sufficient to substantially inhibit cyclin dependent kinases.
Inventor(s): Wang; Longgui (Flushing, NY), Mencher; Simon K. (New York, NY)
Assignee: Natrogen Therapeutics International, Inc. (New York, NY)
Application Number:13/197,164
Patent Claims:see list of patent claims

Details for Patent 8,748,475

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Glaxosmithkline Llc BENLYSTA belimumab For Injection 125370 2011-03-09 ⤷  Try it Free 2024-01-12
Glaxosmithkline Llc BENLYSTA belimumab Injection 761043 2017-07-20 ⤷  Try it Free 2024-01-12
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.